Wird geladen...
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Pancreatic cancer is a highly lethal disease with a poor prognosis, and existing therapies offer only limited effectiveness. Mutation gene sequencing has shown several gene associations that may account for its carcinogenesis, revealing a promising research direction. Poly (ADP-ribose) polymerase (P...
Gespeichert in:
| Veröffentlicht in: | Mol Cancer |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053129/ https://ncbi.nlm.nih.gov/pubmed/32122376 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-020-01167-9 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|